Literature DB >> 25024366

Role for streptococcal collagen-like protein 1 in M1T1 group A Streptococcus resistance to neutrophil extracellular traps.

Simon Döhrmann1, Sabina Anik1, Joshua Olson1, Ericka L Anderson1, Neelou Etesami2, Hyewon No2, Joshua Snipper2, Victor Nizet3, Cheryl Y M Okumura4.   

Abstract

Streptococcal collagen-like protein 1 (Scl-1) is one of the most highly expressed proteins in the invasive M1T1 serotype group A Streptococcus (GAS), a globally disseminated clone associated with higher risk of severe invasive infections. Previous studies using recombinant Scl-1 protein suggested a role in cell attachment and binding and inhibition of serum proteins. Here, we studied the contribution of Scl-1 to the virulence of the M1T1 clone in the physiological context of the live bacterium by generating an isogenic strain lacking the scl-1 gene. Upon subcutaneous infection in mice, wild-type bacteria induced larger lesions than the Δscl mutant. However, loss of Scl-1 did not alter bacterial adherence to or invasion of skin keratinocytes. We found instead that Scl-1 plays a critical role in GAS resistance to human and murine phagocytic cells, allowing the bacteria to persist at the site of infection. Phenotypic analyses demonstrated that Scl-1 mediates bacterial survival in neutrophil extracellular traps (NETs) and protects GAS from antimicrobial peptides found within the NETs. Additionally, Scl-1 interferes with myeloperoxidase (MPO) release, a prerequisite for NET production, thereby suppressing NET formation. We conclude that Scl-1 is a virulence determinant in the M1T1 GAS clone, allowing GAS to subvert innate immune functions that are critical in clearing bacterial infections.
Copyright © 2014, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25024366      PMCID: PMC4187857          DOI: 10.1128/IAI.01921-14

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  48 in total

1.  Low antibody levels against cell wall-attached proteins of Streptococcus pyogenes predispose for severe invasive disease.

Authors:  Per Akesson; Magnus Rasmussen; Ellen Mascini; Ulrich von Pawel-Rammingen; Robert Janulczyk; Mattias Collin; Arne Olsen; Eva Mattsson; Martin L Olsson; Lars Bjorck; Bertil Christensson
Journal:  J Infect Dis       Date:  2004-02-18       Impact factor: 5.226

2.  A Legionella pneumophila collagen-like protein encoded by a gene with a variable number of tandem repeats is involved in the adherence and invasion of host cells.

Authors:  Liesbeth Vandersmissen; Emmy De Buck; Veerle Saels; David A Coil; Jozef Anné
Journal:  FEMS Microbiol Lett       Date:  2010-03-11       Impact factor: 2.742

Review 3.  The global burden of group A streptococcal diseases.

Authors:  Jonathan R Carapetis; Andrew C Steer; E Kim Mulholland; Martin Weber
Journal:  Lancet Infect Dis       Date:  2005-11       Impact factor: 25.071

4.  Binding of the human complement regulators CFHR1 and factor H by streptococcal collagen-like protein 1 (Scl1) via their conserved C termini allows control of the complement cascade at multiple levels.

Authors:  Michael Reuter; Clayton C Caswell; Slawomir Lukomski; Peter F Zipfel
Journal:  J Biol Chem       Date:  2010-09-20       Impact factor: 5.157

5.  Optimized THP-1 differentiation is required for the detection of responses to weak stimuli.

Authors:  E K Park; H S Jung; H I Yang; M C Yoo; C Kim; K S Kim
Journal:  Inflamm Res       Date:  2007-01       Impact factor: 4.575

6.  The IL-8 protease SpyCEP/ScpC of group A Streptococcus promotes resistance to neutrophil killing.

Authors:  Annelies S Zinkernagel; Anjuli M Timmer; Morgan A Pence; Jeffrey B Locke; John T Buchanan; Claire E Turner; Inbal Mishalian; Shiranee Sriskandan; Emanuel Hanski; Victor Nizet
Journal:  Cell Host Microbe       Date:  2008-08-14       Impact factor: 21.023

7.  The group A streptococcal collagen-like protein-1, Scl1, mediates biofilm formation by targeting the extra domain A-containing variant of cellular fibronectin expressed in wounded tissue.

Authors:  Heaven Oliver-Kozup; Karen H Martin; Diane Schwegler-Berry; Brett J Green; Courtney Betts; Arti V Shinde; Livingston Van De Water; Slawomir Lukomski
Journal:  Mol Microbiol       Date:  2012-12-26       Impact factor: 3.501

8.  Molecular mimicry of host sialylated glycans allows a bacterial pathogen to engage neutrophil Siglec-9 and dampen the innate immune response.

Authors:  Aaron F Carlin; Satoshi Uchiyama; Yung-Chi Chang; Amanda L Lewis; Victor Nizet; Ajit Varki
Journal:  Blood       Date:  2009-02-04       Impact factor: 22.113

9.  M protein and hyaluronic acid capsule are essential for in vivo selection of covRS mutations characteristic of invasive serotype M1T1 group A Streptococcus.

Authors:  Jason N Cole; Morgan A Pence; Maren von Köckritz-Blickwede; Andrew Hollands; Richard L Gallo; Mark J Walker; Victor Nizet
Journal:  MBio       Date:  2010-08-31       Impact factor: 7.867

10.  Streptococcal collagen-like surface protein 1 promotes adhesion to the respiratory epithelial cell.

Authors:  Shih-Ming Chen; Yau-Sheng Tsai; Chin-Ming Wu; Shuen-Kuei Liao; Ling-Chia Wu; Cherng-Shyang Chang; Ya-Hui Liu; Pei-Jane Tsai
Journal:  BMC Microbiol       Date:  2010-12-15       Impact factor: 3.605

View more
  13 in total

1.  Natural variant of collagen-like protein a in serotype M3 group a Streptococcus increases adherence and decreases invasive potential.

Authors:  Anthony R Flores; Brittany E Jewell; Erika M Versalovic; Randall J Olsen; Beth A Bachert; Slawomir Lukomski; James M Musser
Journal:  Infect Immun       Date:  2015-01-05       Impact factor: 3.441

Review 2.  Cationic antimicrobial peptide resistance mechanisms of streptococcal pathogens.

Authors:  Christopher N LaRock; Victor Nizet
Journal:  Biochim Biophys Acta       Date:  2015-02-17

Review 3.  Collagen-like proteins of pathogenic streptococci.

Authors:  Slawomir Lukomski; Beth A Bachert; Flavia Squeglia; Rita Berisio
Journal:  Mol Microbiol       Date:  2017-01-18       Impact factor: 3.501

4.  Role for Cell-Surface Collagen of Streptococcus pyogenes in Infections.

Authors:  Aubrey J Ellison; Felix Dempwolff; Daniel B Kearns; Ronald T Raines
Journal:  ACS Infect Dis       Date:  2020-06-03       Impact factor: 5.084

Review 5.  Neutrophil Extracellular Traps in Host Defense.

Authors:  Sabrina Sofia Burgener; Kate Schroder
Journal:  Cold Spring Harb Perspect Biol       Date:  2020-07-01       Impact factor: 9.708

6.  Genome-wide discovery of novel M1T1 group A streptococcal determinants important for fitness and virulence during soft-tissue infection.

Authors:  Yoann Le Breton; Ashton T Belew; Jeffrey A Freiberg; Ganesh S Sundar; Emrul Islam; Joshua Lieberman; Mark E Shirtliff; Hervé Tettelin; Najib M El-Sayed; Kevin S McIver
Journal:  PLoS Pathog       Date:  2017-08-23       Impact factor: 6.823

7.  Unique Footprint in the scl1.3 Locus Affects Adhesion and Biofilm Formation of the Invasive M3-Type Group A Streptococcus.

Authors:  Beth A Bachert; Soo J Choi; Paul R LaSala; Tiffany I Harper; Dudley H McNitt; Dylan T Boehm; Clayton C Caswell; Pawel Ciborowski; Douglas R Keene; Anthony R Flores; James M Musser; Flavia Squeglia; Daniela Marasco; Rita Berisio; Slawomir Lukomski
Journal:  Front Cell Infect Microbiol       Date:  2016-08-31       Impact factor: 5.293

8.  Group A Streptococcus Prevents Mast Cell Degranulation to Promote Extracellular Trap Formation.

Authors:  Mary Clark; Jessica Kim; Neelou Etesami; Jacqueline Shimamoto; Ryan V Whalen; Gary Martin; Cheryl Y M Okumura
Journal:  Front Immunol       Date:  2018-02-27       Impact factor: 7.561

Review 9.  Molecular and genomic characterization of pathogenic traits of group A Streptococcus pyogenes.

Authors:  Shigeyuki Hamada; Shigetada Kawabata; Ichiro Nakagawa
Journal:  Proc Jpn Acad Ser B Phys Biol Sci       Date:  2015       Impact factor: 3.493

Review 10.  Conquering Neutrophils.

Authors:  Simon Döhrmann; Jason N Cole; Victor Nizet
Journal:  PLoS Pathog       Date:  2016-07-28       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.